Skip to Main Content

Paper Details

Pembrolizumab monotherapy in metastatic triple-negative breast cancer.
Lancet Oncol
2
2021
Author NameAffiliation
David W CesconPrincess Margaret Cancer Centre and the University of Toronto
  • 1 - 1

Datasets

Release 1.2